Search Results

Alzheimer's disease: Seeing the signs early

Author: Leifer, Bennett P.

Source: Journal of the American Academy of Nurse Practitioners, Volume 21, Number 11, November 2009 , pp. 588-595(8)

Publisher: Blackwell Publishing

Cholinesterase Inhibitors and Incidence of Bradycardia in Patients with Dementia in the Veterans Affairs New England Healthcare System

Authors: Hernandez, Rohini K.; Farwell, Wildon; Cantor, Michael D.; Lawler, Elizabeth V.

Source: Journal of the American Geriatrics Society, Volume 57, Number 11, November 2009 , pp. 1997-2003(7)

Publisher: Blackwell Publishing

Donepezil: Atrioventricular block and torsade de pointes in elderly patients: 2 case reports

Source: Reactions, Volume 1, Number 1277, 2009-11-07 , pp. 18-18(1)

Publisher: Adis International

Mediators of tau phosphorylation in the pathogenesis of Alzheimer's disease

Authors: Hanger, Diane P; Seereeram, Anjan; Noble, Wendy

Source: Expert Review of Neurotherapeutics, Volume 9, Number 11, November 2009 , pp. 1647-1666(20)

Publisher: Expert Reviews

Donepezil treatment in severe Alzheimer's disease: a pooled analysis of three clinical trials

Authors: Winblad, Bengt; Black, Sandra E.; Homma, Akira; Schwam, Elias M.; Moline, Margaret; Xu, Yikang; Perdomo, Carlos A.; Swartz, Jina; Albert, Kenneth

Source: Current Medical Research and Opinion, Volume 25, Number 11, November 2009 , pp. 2577-2587(11)

Publisher: Informa Healthcare

Cerebrolysin: A Review of its Use in Dementia

Authors: Plosker, Greg L.; Gauthier, Serge

Source: Drugs & Aging, Volume 26, Number 11, 1 November 2009 , pp. 893-915(23)

Publisher: Adis International

First analysis of pharma uptake after NICE approval

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 587, 2009-09-19 , pp. 5-5(1)

Publisher: Adis International

Occupational contact urticaria caused by donepezil

Authors: Lozano, Jose Manuel Galvez; Alcantara, Manuel; De San Pedro, Blanca Saenz; Quiralte, Joaquin; Caba, Isabel

Source: Contact Dermatitis, Volume 61, Number 3, September 2009 , pp. 176-176(1)

Publisher: Blackwell Publishing

Case Report: Combined Use of Donepezil and Galantamine in Mixed Dementia

Authors: Obering, Crystal; Batrash, Ahmad

Source: Journal of the American Geriatrics Society, Volume 57, Number 10, October 2009 , pp. 1934-1935(2)

Publisher: Blackwell Publishing

Few pharmacological options available for treating cognitive impairment associated with severe Alzheimer's disease

Author: Adis International Limited,

Source: Drugs & Therapy Perspectives, Volume 25, Number 10, October 2009 , pp. 9-11(3)

Publisher: Adis International

Memantine: A Review of its Use in Moderate to Severe Alzheimer's Disease

Author: McKeage, Kate

Source: CNS Drugs, Volume 23, Number 10, 1 October 2009 , pp. 881-897(17)

Publisher: Adis International

Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium

Authors: Kakinuma, Yoshihiko; Akiyama, Tsuyoshi; Sato, Takayuki

Source: FEBS Journal, Volume 276, Number 18, September 2009 , pp. 5111-5125(15)

Publisher: Blackwell Publishing

HOW TO MANAGE OVERACTIVE BLADDER IN ELDERLY INDIVIDUALS WITH DEMENTIA? A COMBINED USE OF DONEPEZIL, A CENTRAL ACETYLCHOLINESTERASE INHIBITOR, AND PROPIVERINE, A PERIPHERAL MUSCARINE RECEPTOR ANTAGONIST

Authors: Sakakibara, Ryuji; Ogata, Takeshi; Uchiyama, Tomoyuki; Kishi, Masahiko; Ogawa, Emina; Isaka, Shigeo; Yuasa, Joji; Yamamoto, Tatsuya; Ito, Takashi; Yamanishi, Tomonori; Awa, Yusuke; Yamaguchi, Chiharu; Takahashi, Osamu

Source: Journal of the American Geriatrics Society, Volume 57, Number 8, August 2009 , pp. 1515-1517(3)

Publisher: Blackwell Publishing

Treatment of Mild Cognitive Impairment (MCI)

Author: Farlow, M. R.

Source: Current Alzheimer Research, Volume 6, Number 4, August 2009 , pp. 362-367(6)

Publisher: Bentham Science Publishers

Donepezil: a guide to its use in Alzheimer's disease

Author: Adis International Limited,

Source: Drugs & Therapy Perspectives, Volume 25, Number 9, September 2009 , pp. 5-8(4)

Publisher: Adis International

A cost-effectiveness study has added fuel to the debate over the UK's decision to restrict cholinesterase inhibitor use to moderate Alzheimer's disease (AD).

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 584, 2009-08-08 , pp. 5-5(1)

Publisher: Adis International

Response to “Results, Rhetoric, and Randomized Trials: The Case of Donepezil”

Author: Lisi, Donna

Source: Journal of the American Geriatrics Society, Volume 57, Number 7, July 2009 , pp. 1317-1318(2)

Publisher: Blackwell Publishing

Clinical effects of high oral dose of donepezil for patients with Alzheimer's disease in Japan

Authors: NOZAWA, Motohiro; ICHIMIYA, Yosuke; NOZAWA, Eiko; UTUMI, Yushi; SUGIYAMA, Hideki; MURAYAMA, Norio; ISEKI, Eizo; ARAI, Heii

Source: Psychogeriatrics, Volume 9, Number 2, June 2009 , pp. 50-55(6)

Publisher: Blackwell Publishing

The serotonin 5-HT₆ receptor: a viable drug target for treating cognitive deficits in Alzheimer's disease

Authors: Geldenhuys, Werner J; Van der Schyf, Cornelis J

Source: Expert Review of Neurotherapeutics, Volume 9, Number 7, July 2009 , pp. 1073-1085(13)

Publisher: Expert Reviews

Cholinesterase inhibitory effects of Rhizophora lamarckii, Avicennia officinalis, Sesuvium portulacastrum and Suaeda monica: Mangroves inhabiting an Indian coastal area (Vellar Estuary)

Authors: Suganthy, Natarajan; Pandian, Shanmugiahthevar Karutha; Devi, Kasi Pandima

Source: Journal of Enzyme Inhibition and Medicinal Chemistry, Volume 24, Number 3, June 2009 , pp. 702-707(6)

Publisher: Informa Healthcare